BioSpace News Archive

Deals

QXMédical Licenses Bioresorbable Embolic Technology from U of MN

Drug loadable and bioresorbable embolic microspheres and hydrogels offer the potential for controlled and predictable drug release and resorption for treatment of tumors, bleeding and cancer

June 10, 2019
·
3 min read
The Isaac Foundation Launches #AccessForAll, calls for increased access to innovative therapies and collaborative access solutions

The Isaac Foundation, a registered Canadian charity committed to supporting and advocating on behalf of patients and families coping with rare diseases, launched a national awareness program designed to call attention to the issues related to access to innovative therapies in Canada.

June 10, 2019
·
3 min read
Business

Hi-Tech Pharmaceuticals Expands Production Capabilities in Dietary Supplement and OTC Drug Manufacturing

Hi-Tech has Four Ultramodern facilities for producing Tablets, Capsules, Liquids, Creams, RTD’s, Animal Health products and powders.

June 10, 2019
·
6 min read
Business

Thermo Fisher Scientific and Roper Technologies Announce Termination of Gatan Acquisition

Existing Supply Agreement Remains Intact

June 10, 2019
·
2 min read
Lone Star Bio

Trumm Drug Named Health Mart Pharmacy of the Year

One of seven top-performing pharmacies recognized for exceptional patient care, operational innovation and community commitment

June 10, 2019
·
3 min read
Business

AAC Publishes Investor Presentation Detailing Strategies and State of Current Operations

AAC Holdings, Inc. has made available a new investor presentation detailing the Company’s current operations and strategies.

June 10, 2019
·
1 min read
Drug Development

Collaborative Medicinal Development, LLC Reports that Lead Drug Shows Dose-Dependent Improvement in Parkinson’s Disease

Collaborative Medicinal Development LLC, will report promising results from its phase 1, non-placebo controlled, dose-finding study of CuATSM for treatment of Parkinson’s Disease at the XXIV World Congress on Parkinson’s Disease and Related Disorders to be held in Montreal, Canada from June 16-19, 2019.

June 10, 2019
·
2 min read
BioForest

BioLife Solutions to Join Russell 3000® Index

Effective after the US market opens on July 1, according to a preliminary list of additions posted June 7.

June 10, 2019
·
4 min read
BioMidwest

First patients successfully treated in the Nuvaira AIRFLOW-3 COPD pivotal trial

A first for Temple University Hospital and U.S. Patients

June 10, 2019
·
2 min read
Drug Development

FARXIGA Study Showed Reduced Progression of Kidney Disease or Renal Death in Patients with Type 2 Diabetes

FARXIGA showed a 47% reduction in the composite of kidney function decline, end-stage renal disease or renal death in a pre-specified analysis from DECLARE-TIMI 58

June 10, 2019
·
9 min read